Company Analysis Hims & Hers Health, Inc.
1. Summary
Advantages
- The stock's return over the last year (94.81%) is higher than the sector average (0%).
- Current debt level 1.6% is below 100% and has decreased over 5 years from 2.08%.
- The company's current efficiency (ROE=30.71%) is higher than the sector average (ROE=10.81%)
Disadvantages
- Price (55.5 $) is higher than fair price (7.68 $)
- Dividends (0%) are below the sector average (1.17%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Hims & Hers Health, Inc. | High Tech | Index | |
---|---|---|---|
7 days | 11.8% | -3.6% | 0.8% |
90 days | 10.4% | 8.5% | 11% |
1 year | 94.8% | 0% | 16.1% |
HIMS vs Sector: Hims & Hers Health, Inc. has outperformed the "High Tech" sector by 94.81% over the past year.
HIMS vs Market: Hims & Hers Health, Inc. has outperformed the market by 78.74% over the past year.
Stable price: HIMS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HIMS with weekly volatility of 1.82% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (55.5 $) is higher than the fair price (7.68 $).
Price is higher than fair: The current price (55.5 $) is 86.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (45.43) is lower than that of the sector as a whole (57.75).
P/E vs Market: The company's P/E (45.43) is lower than that of the market as a whole (51.19).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (12.01) is higher than that of the sector as a whole (7.53).
P/BV vs Market: The company's P/BV (12.01) is lower than that of the market as a whole (18.13).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.88) is higher than that of the sector as a whole (3.77).
P/S vs Market: The company's P/S indicator (3.88) is lower than that of the market as a whole (27.99).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (69.84) is higher than that of the sector as a whole (29.07).
EV/Ebitda vs Market: The company's EV/Ebitda (69.84) is higher than that of the market as a whole (36.56).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -159.27% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-159.27%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-807.84%).
5.4. ROE
ROE vs Sector: The company's ROE (30.71%) is higher than that of the sector as a whole (10.81%).
ROE vs Market: The company's ROE (30.71%) is lower than that of the market as a whole (34.77%).
5.5. ROA
ROA vs Sector: The company's ROA (21.94%) is higher than that of the sector as a whole (4.62%).
ROA vs Market: The company's ROA (21.94%) is higher than that of the market as a whole (11.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-23%) is lower than that of the sector as a whole (-13.4%).
ROIC vs Market: The company's ROIC (-23%) is lower than that of the market as a whole (10.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription